Merck KGaA (ADR)

General ticker "MKKGY" information:

  • Sector: Health Care
  • Industry: Drug Manufacturers - Specialty & Generic
  • Capitalization: $59.3B (TTM average)

Merck KGaA (ADR) follows the US Stock Market performance with the rate: 35.3%.

Estimated limits based on current volatility of 1.4%: low 24.44$, high 25.16$

Factors to consider:

  • Company pays dividends (annually): last record date 2025-04-29, amount 0.50$ (Y2.00%)
  • Price in estimated range

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

  • 2025-12-31 to 2026-12-31 estimated range: [22.59$, 33.19$]
  • 2026-12-31 to 2027-12-31 estimated range: [23.32$, 34.23$]

Similar symbols

Short-term MKKGY quotes

Long-term MKKGY plot with estimates

Financial data

YTD 2023-12-31 2024-12-31 2025-12-31
Operating Revenue €20,993.00MM €21,156.00MM €20,269.16MM
Operating Expenses €17,384.00MM €17,511.00MM €16,364.60MM
Operating Income €3,609.00MM €3,645.00MM €3,904.57MM
Non-Operating Income €-125.00MM €-109.00MM €-727.12MM
Interest Expense €272.00MM €292.00MM €251.66MM
R&D Expense €2,445.00MM €2,279.00MM €2,287.99MM
Income(Loss) €3,484.00MM €3,536.00MM €3,177.44MM
Taxes €650.00MM €751.00MM €665.65MM
Profit(Loss)* €2,824.00MM €2,777.00MM €2,505.07MM
Stockholders Equity €26,680.00MM €29,912.00MM €28,579.83MM
Inventory €4,637.00MM €4,484.00MM €4,560.06MM
Assets €48,495.00MM €51,567.00MM €52,077.83MM
Operating Cash Flow €3,784.00MM €4,586.00MM €3,776.81MM
Capital expenditure €2,023.00MM €2,184.00MM €1,521.48MM
Investing Cash Flow €-1,892.00MM €-3,050.00MM €-4,092.83MM
Financing Cash Flow €-1,732.00MM €-985.00MM €603.21MM
Earnings Per Share** €1.30 €1.28 €1.15
Ordinary share to ADR 1.00x 1.00x 1.00x

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.